Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Jeffrey A. GravesDirector | Integra Lifesciences HoldingsIART | Open-market buy | 25/11/05 | 25/11/06 | 9,000 sh | $11.35 | $102,150 | +28.0% |
Eric SchwartzEVP, Chief Legal Officer & Sec | Integra Lifesciences HoldingsIART | Open-market sale | 24/12/03 | 24/12/04 | 4,070 sh | $24.60 | $100,122 | −6.4% |
Michael J. McBreenEVP & President, CSS | Integra Lifesciences HoldingsIART | Open-market sale | 24/12/02 | 24/12/03 | 1,700 sh | $24.16 | $41,072 | −2.9% |
Jeffrey MosebrookSVP, Fin & Princ Acct Officer | Integra Lifesciences HoldingsIART | Open-market sale | 24/08/19 | 24/08/20 | 1,191 sh | $21.58 | $25,701.78 | −3.2% |
Stuart EssigExec. Chairman | Integra Lifesciences HoldingsIART | Open-market buy | 24/05/23 | 24/05/24 | 52,641 sh | $28.49 | $1,499,742.09 | +12.1% |
Barbara B. HillDirector | Integra Lifesciences HoldingsIART | Open-market buy | 24/05/21 | 24/05/22 | 36,350 sh | $27.40 | $995,990 | No record |
Robert T. Davis Jr.EVP & President, TT | Integra Lifesciences HoldingsIART | Open-market sale | 24/03/06 | 24/03/08 | 8,348 sh | $36.59 | $305,453.32 | −14.3% |
Jeffrey MosebrookSVP, Fin & PAO | Integra Lifesciences HoldingsIART | Open-market sale | 23/08/09 | 23/08/10 | 1,177 sh | $44.46 | $52,329.42 | −4.8% |
Eric SchwartzEVP, Chief Legal Officer & Sec | Integra Lifesciences HoldingsIART | Open-market buy | 23/06/01 | 23/06/05 | 2,640 sh | $37.89 | $100,029.6 | +5.7% |
Jan De WittePresident & CEO | Integra Lifesciences HoldingsIART | Open-market buy | 23/06/01 | 23/06/02 | 7,792 sh | $38.50 | $299,992 | +155.7% |
Michael J. McBreenEVP & President, CSS | Integra Lifesciences HoldingsIART | Open-market sale | 23/03/07 | 23/03/08 | 1,843 sh | $54.29 | $100,056.47 | −6.0% |
Robert T. Davis Jr.EVP & President, TT | Integra Lifesciences HoldingsIART | Open-market sale | 23/03/01 | 23/03/03 | 1,566 sh | $55.21 | $86,458.86 | −3.3% |
Lisa EvoliEVP & Chro | Integra Lifesciences HoldingsIART | Open-market sale | 23/02/27 | 23/02/28 | 3,767 sh | $57.00 | $214,719 | −16.8% |